| Mixed Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived103 of 103show fewer |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 45 trials (10 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 38 trials (11 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 32 trials (9 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 26 trials (8 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 22 trials (5 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 19 trials (8 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 13 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 12 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 12 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactinomycinother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ensartinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ivosidenibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Samotolisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aminolevulinic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bafetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elacestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirvetuximab Soravtansineadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trabectedinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mixed Neoplasm | 1 | Observed | clinicaltrials | graph → |